| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Drusano GL | |
| P921 | main subject | pharmacodynamics | Q725307 |
| P304 | page(s) | 235-248 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Scandinavian journal of infectious diseases. Supplementum | Q27713381 |
| P1476 | title | Human pharmacodynamics of beta-lactams, aminoglycosides and their combination | |
| P478 | volume | 74 |
| Q35122080 | Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole |
| Q35126312 | Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods. |
| Q35135561 | Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations |
| Q77634765 | Continuous infusion of beta-lactam antibiotics |
| Q34161745 | General principles of antimicrobial therapy |
| Q35117021 | In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa |
| Q35941284 | In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection |
| Q39557221 | Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept |
| Q35637864 | Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC |
| Q39559375 | MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model |
| Q28483752 | Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle |
| Q35820928 | Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa |
| Q35820708 | Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections |
| Q40392377 | Parenteral aminoglycoside therapy. Selection, administration and monitoring |
| Q36670352 | Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria |
| Q72811534 | Pharmacokinetic characteristics of piperacillin/tazobactam |
| Q40589859 | Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides |
| Q36911111 | Pharmacokinetics and pharmacodynamics of antibacterial agents |
| Q35900491 | Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery |
| Q35137735 | Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children |
| Q35191390 | Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms |
| Q35758804 | Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice |
| Q38572705 | Quantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging |
| Q39867395 | Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children |
| Q39779693 | Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses |
| Q40517235 | The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents |
| Q93053124 | The pharmacodynamic bases of the prescription of antimicrobials |
| Q34140899 | Use of Modeling Techniques to Aid in Antibiotic Selection |
Search more.